Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114294Source: DataRank Database

Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders is a research paper published in Journal of Controlled Release (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.40)OA: closedTopics (46)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Kobra Rostamizadeh ORCID,Nicholas Skiados ORCID,Nguyet‐Minh Nguyen Le ORCID,Debra Walter,Bryan Hannon

Live enrichment

PubMed:41061858 OpenAlex:https://openalex.org/W4414871811

National Institute on Drug Abuse

Grant: 5UG3DA048775-02

National Institute on Drug Abuse

Grant: F31 DA059235

National Science Foundation

Grant: NNCI-2025489

National Science Foundation

Grant: NNCI-1542101

FWCI

1.40

Citation Percentile

0.8%

Citation Trend

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0168365925009071?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365925009071?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2025.114294

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41061858

Fields of Study

Neuropeptides and Animal PhysiologyAdvanced Drug Delivery SystemsPharmacological Receptor Mechanisms and EffectsAnimalsImmunity, InnateVaccinesNanoparticlesOpioid-Related DisordersOxycodoneMaleRats, Sprague-DawleyFentanylRatsFemaleAnalgesics, OpioidMiceLipidsHumans

MeSH Terms

Analgesics, OpioidAnimalsFemaleFentanylHumansImmunity, InnateLipidsMaleOpioid-Related DisordersOxycodoneVaccinesRats, Sprague-DawleyMiceRatsNanoparticles

Keywords

OxycodoneImmunogenicityImmune systemInnate immune systemImmunizationCytokineOpioidAgonistResiquimod®fentanylhybrid lipid-polymeric nanoparticlesnanovaccinetoll-like receptors

Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics